fluorodeoxyglucose f18 has been researched along with Neoplasm Metastasis, Unknown Primary in 219 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 12 (5.48) | 18.2507 |
| 2000's | 99 (45.21) | 29.6817 |
| 2010's | 86 (39.27) | 24.3611 |
| 2020's | 22 (10.05) | 2.80 |
| Authors | Studies |
|---|---|
| Amit, U; Baron, L; Barshack, I; Davidson, T; Nissan, E; Urban, D; Zabatani, A | 1 |
| Awad, Z; Bujoreanu, I; Gujral, D; Wallitt, K | 1 |
| Alberto Vargas, H; Becker, AS; Do, RKG; Hricak, H; Schöder, H; Woo, S | 1 |
| Huang, R; Huang, S; Qi, Z; Su, M | 1 |
| Atilgan, HI; Yalcin, H | 1 |
| Baugnon, KL; Fischbein, NJ; Mukherjee, S; Policeni, BA; Raghavan, P | 1 |
| Araujo-Chumacero, MM; Barreto, L; Barreto-Acevedo, E; Quispe-Huamaní, EV; Rodríguez-Kadota, L; Saavedra-Rocha, C; Urrunaga-Pastor, D; Vences, MA | 1 |
| Delluc, A; Robin, P | 1 |
| Born, D; Broglie, MA; Hüllner, MW; Kovacs, Z; Maurer, A; Morand, GB; Nemes, CM; Nemmour, A; Pazahr, S; Rupp, NJ; Serrallach, B; Stadler, TM; Stoeckli, SJ | 1 |
| Cai, L; Chen, X; Chen, Y; Deng, M; Hu, M; Liu, M; Shu, Q | 1 |
| Röhrich, M | 1 |
| Arshad, H; Bogart, JA; Chowdhry, V; Degraaf, L; Farrugia, M; Gupta, V; Hahn, SS; Hicks, WL; Iovoli, A; Lacombe, MA; Mix, M; Platek, A; Platek, ME; Singh, AK; Wooten, K | 1 |
| Campbell, F; Crosbie, R; Easton, F; Grose, D; James, A; Lamb, C; McLoone, P; Paterson, C; Poon, WY; Rizwanullah, M; Schipani, S; Thomson, M; Wilson, C | 1 |
| Chen, Y; Hou, Y; Hu, S; Hu, X; Li, W; Liu, X; Luo, Z; Shao, Y; Wang, Q; Wang, Y; Zhang, Y; Zhou, X | 1 |
| Greenberg, DD | 1 |
| Beckers, M; Le Gal, G; Le Roux, PY; Lecumberri, R; Robin, P; Rondina, M; Salaun, PY; van Es, N | 1 |
| Asenov, YN; Dineva, SE; Grudeva, VV; Hadzhiyska, VH; Ilcheva, MG; Mladenov, KB; Nikolova, PN; Veneva, S | 1 |
| Fries, F | 1 |
| Iizuka, H; Ishiwata, Y; Kaneta, T; Nawata, S; Utsunomiya, D | 1 |
| Han, J; Li, F; Li, X; Li, Y; Qu, L | 1 |
| Chen, B; Gao, S; Ji, B; Liu, D; Wang, X; Zhang, H | 1 |
| Aher, PY; Graham, MM; Maheshwarappa, RP; Mishra, P; Ora, M; Priya, S; Soni, N | 1 |
| Al-Mamgani, A; de Boer, J; de Ridder, M; Hamming-Vrieze, O; Jasperse, B; Klop, M; Smit, L; van den Brekel, M; Vogel, W | 1 |
| Burglin, SA; Gerke, O; Hess, S; Høilund-Carlsen, PF | 1 |
| Couturaud, F; Le Gal, G; Le Moigne, E; Le Roux, PY; Merah, A; Pastre, J; Planquette, B; Prévot-Bitot, N; Robin, P; Roy, PM; Salaun, PY | 1 |
| Allinson, K; Candy, N; Carr, O; McMillen, J; Trivedi, R; Young, A | 1 |
| Dong, P; Li, L; Su, M; Tian, R | 1 |
| Andratschke, N; Berghoff, AS; Dummer, R; Frauenfelder, T; Füreder, LM; Kaufmann, PA; Le Rhun, E; Leske, H; Neidert, MC; Petyt, G; Preusser, M; Regli, L; Reyns, N; Roth, P; Rushing, E; Stahel, R; Stupp, R; Weller, M; Wolpert, F | 1 |
| Dağtekin, A; Kara, PÖ; Koç, ZP | 1 |
| Couturaud, F; Kumar, S; Le Gal, G; Le Roux, PY; Merah, A; Planquette, B; Robin, P; Roy, PM; Salaun, PY; Thavorn, K | 1 |
| Connor, S; Cook, GJ; Dunn, J; Guerrero-Urbano, T; Jeannon, JP; Lei, M; Oakley, R; Pencharz, D; Siddiqui, A; Sriskandan, N; Szyszko, TA; Thavaraj, S | 1 |
| Fu, L; Li, W; Tian, X | 1 |
| Eisele, DW; Fakhry, C; Gourin, CG; Motz, KM; Mydlarz, WK; Quon, H; Rooper, LM; Ryan, JF; Tan, M | 1 |
| Liu, Y | 2 |
| Bom, HS; Chowdhury, MSA; Jeon, S; Kwon, SY; Min, JJ | 1 |
| Javadi, MS; Rowe, SP; Solnes, LB; Tulbah, RI | 1 |
| Agrawal, A; Kulkarni, M; Purandare, N; Rangarajan, V; Shah, S; Zade, A | 1 |
| Chang, CC; Chen, YW; Hou, MF; Huang, CJ; Lin, CY; Yang, WC | 1 |
| Alfonso, A; Del Olmo, B; García-Velloso, MJ; Lecumberri, R; Páramo, JA; Redondo, M; Richter, JA; Rodríguez-Wilhelmi, P; Rubio, T | 1 |
| Wang, N; Zhu, L | 1 |
| Ganeshan, D; Hanlon, R; Lewis-Jones, H; Prowse, PM; Prowse, SJ; Shaw, R; Wieshmann, H | 1 |
| de Wet, C; Deonarine, P; Han, S; Poon, FW | 1 |
| Behrendt, FF; Breuer, N; Heinzel, A; Mottaghy, FM; Palmowski, M; Verburg, FA | 1 |
| Baum, RP; Hommann, M; Hörsch, D; Kaemmerer, D; Kulkarni, HR; Robiller, F | 1 |
| Baek, JH; Cho, KJ; Choi, SH; Kim, JS; Kim, SY; Lee, JH; Lee, JR; Nam, SY; Roh, JL | 1 |
| Atallah, I; Berta, E; Boyer, E; Karkas, A; Reyt, E; Righini, CA | 1 |
| Aktolun, C; Basibuyuk, M; Celen, YZ; Elboga, U; Kervancioğlu, S; Sahin, E | 1 |
| Banzo, I; Carril, JM; Jiménez-Bonilla, J; Martínez-Rodríguez, I; Quirce, R | 1 |
| Besenyi, Z; Csenki, M; Cserháti, A; Dobi, Á; Együd, Z; Gaál, S; Hideghéty, K; Lengyel, Z; Maráz, A; Mózes, P; Pávics, L; Rusz, O; Szántó, E; Varga, Z; Zag, L | 1 |
| Basu, S; Pawaskar, AS | 1 |
| Baek, JH; Cho, SH; Choi, YJ; Kim, DY; Kim, HO; Kim, N; Kim, SY; Koh, MJ; Lee, JH; Yoon, RG | 1 |
| Jain, AS; Muthukrishnan, I; Panneer, V; Simon, S; Srivastava, MK | 1 |
| Anwar, B; George, MM; Homer, JJ; Mani, N; Nash, L | 1 |
| Accassat, S; Couturaud, F; Couturier, O; Delluc, A; Ghazzar, N; Le Gal, G; Le Roux, PY; Planquette, B; Prevot-Bitot, N; Robin, P; Roy, PM; Salaun, PY; Sanchez, O; Tardy, B | 1 |
| Cunningham, I; Kohno, B | 1 |
| Servaes, S; Zhang, W; Zhuang, H | 1 |
| Arellano, R; Lopez, E | 1 |
| Feng, Z; Huang, Y; Liang, X; Shi, W; Wang, S; Zhang, B | 1 |
| Chen, G; Fu, Z; Li, Q; Li, Z; Liu, M | 1 |
| Duan, F; Hanna, L; Hillner, BE; Sachedina, A; Shields, AF; Siegel, BA; Subramaniam, RM | 1 |
| Kiraç, FS; Yaylali, O; Yüksel, D | 1 |
| Chen, SS; Hsieh, CH; Kang, CJ; Liao, CT; Lin, CY; Su, YY; Yen, TC | 1 |
| Bai, R; Li, J; Li, Y; Ma, Y; Shi, H; Wang, C; Xiao, J; Xu, W; Yang, C; Yu, H; Zhang, J | 1 |
| Bogsrud, TV; Dale, E; Moan, JM; Osnes, TA | 1 |
| Boulahdour, H; Drouet, C; Morel, O | 1 |
| Bellendorf, A; Bockisch, A; Forsting, M; Grafe, H; Grueneisen, J; Ruhlmann, M; Ruhlmann, V; Sawicki, LM; Umutlu, L | 1 |
| Gődény, M; Kásler, M; Lengyel, Z; Léránt, G; Nagy, ZT; Polony, G; Remenár, É; Tamás, L; Zámbó, O | 1 |
| Barbosa, FG; Burger, IA; Delso, G; Huellner, MW; Mader, CE; Sah, BR; Sekine, T; Stolzmann, P; Ter Voert, EE; Veit-Haibach, P; von Schulthess, GK | 1 |
| Dong, L; Han, T; Lin, Q; Liu, B; Liu, M; Wang, X | 1 |
| Aimoni, C; Padovani, D; Paluzzi, A; Pastore, A; Zucchetta, P | 1 |
| Cook, G; Harrington, KJ; Newbold, KL; Nutting, CM; Partridge, M; Rhys-Evans, P; Sharma, B | 1 |
| Cho, KJ; Choi, SH; Kim, JS; Kim, SY; Lee, JH; Nam, SY; Roh, JL | 1 |
| Kwee, RM; Kwee, TC | 1 |
| Fujino, T; Harasawa, A; Mochizuki, K; Morii, T; Sano, H; Satomi, K | 1 |
| Hu, M; Kong, L; Li, MH; Liu, NB; Yang, GR; Yu, JM | 1 |
| Podoloff, DA | 1 |
| Mukai, H | 1 |
| Bai, CM; Meng, QL; Ning, XH; Wang, YZ | 1 |
| Alavi, A; Basu, S; Cheng, G; Kwee, TC | 1 |
| Mercier, G; Peller, P; Sakai, O; Subramaniam, RM; Truong, M | 1 |
| Aydin, M; Buyukdereli, G; Disel, U; Erkisi, M; Kara, O; Kelle, AP; Kibar, M; Paydas, S; Reyhan, M; Sahin, B; Unal, I; Yapar, AF; Yapar, Z; Yavuz, S | 1 |
| Iizuka, Y; Shinozaki, T; Takagishi, K; Watanabe, H; Yanagawa, T | 1 |
| Jovanović, D; Lucić, MA; Lucić, SM; Peter, A; Vucaj-Cirilović, V | 1 |
| Flucke, U; Kaal, S; Leenders, W; Oyen, W; van de Luijtgaarden, A; van der Graaf, W; van der Ven, A | 1 |
| Halnaik, D; Solav, S | 1 |
| Horiuchi, C; Nishimura, G; Taguchi, T; Tsukuda, M; Yabuki, K | 1 |
| de Bree, R | 1 |
| Al-Nahhas, A; Barwick, T; Howard, DJ; Patel, NH; Salem, S; Win, Z; Zerizer, I | 1 |
| Agarwal, MG; Agrawal, A; Asopa, RV; Jagtap, V; Jambhekar, NA; Kulkarni, M; Malhotra, G; Sarathi, V; Shah, NS | 1 |
| Bonardel, G; Carette, MF; de Labriolle-Vaylet, C; Grahek, D; Housset, B; Lebeau, B; Mangiapan, G; Margery, J; Meignan, M; Milleron, B; Talbot, JN; Vaylet, F | 1 |
| Bammens, B; Hermans, G; Kuypers, D; Meersseman, P; Meersseman, W; Sciot, R; Van Aken, B | 1 |
| Kim, BS; Kim, IJ; Kim, K; Kim, SJ; Kim, YK; Nam, HY; Pak, K | 1 |
| Aschoff, P; Pfannenberg, C; Reimold, M; Werner, MK | 1 |
| Alavi, A; Basu, S; Kwee, TC | 1 |
| Berthelsen, AK; Christensen, CB; Damgaard Pedersen, K; Daugaard, G; Graff, J; Loft, A; Moller, AK; Perell, K; Petersen, BL | 1 |
| Domae, S; Hamaya, K; Hirai, M; Miki, K; Nose, S; Noyama, Y; Orita, Y | 1 |
| Briggs, RH; Chowdhury, FU; Lodge, JP; Scarsbrook, AF | 1 |
| Godballe, C; Grau, C; Johansen, J; Loft, A; Petersen, H | 1 |
| Collyer, JC; Ghazali, N; Tighe, J | 1 |
| Cui, L; Gao, J; Guan, Z; Shen, Z; Tian, J; Wang, H; Xu, B; Yao, S | 1 |
| Bhattacharya, A; Gupta, A; Kulkarni, P; Manohar, K; Mittal, BR; Singh, N | 1 |
| de Casso, C; Kane, T; Nigam, A; Soni-Jaiswall, A; Visvanathan, V | 1 |
| Chen, YH; He, JJ; Li, SS; Liu, JJ; Wang, S; Wang, YH; Yang, XM; Yang, YD; Zhang, XL | 1 |
| Arnold, SE; Bromham, NR; Taylor, MB | 1 |
| Nguyen, BD; Nguyen, VX; Ram, PC | 1 |
| Han, A; Hu, M; Wang, X; Xue, J; Zheng, J | 1 |
| Andersen, KF; Bülow, J; Skøt, J; Suetta, C | 1 |
| Borbély, K; Fülöp, M; Kásler, M; Lengyel, Z; Remenár, E | 1 |
| Berthelsen, AK; Christensen, CB; Costa, JC; Daugaard, G; Graff, J; Loft, A; Møller, AK; Pedersen, KD; Perell, K; Petersen, BL; Skovgaard, LT | 1 |
| Mahmood, S; Rodríguez Martínez de Llano, S | 1 |
| Dong, MJ; Lin, LL; Liu, JH; Lu, ZJ; Luo, XM; Yan, SX; Yang, SY; Zhao, K; Zhou, SH | 1 |
| Wiggins, RH; Zollinger, LV | 1 |
| Funk, GF | 1 |
| Duch, J | 1 |
| Cho, KJ; Choi, SH; Kim, JS; Kim, SY; Lee, HJ; Lee, JH; Nam, SY; Park, GC; Roh, JL | 1 |
| García-Vicente, AM; Palomar-Muñoz, AM; Pilkington-Woll, JP; Poblete-García, VM; Soriano-Castrejón, A; Talavera-Rubio, Mdel P | 1 |
| Eker, O; Guveli, TK; Mulazimoglu, M; Ozpacaci, T; Tamam, C; Tamam, MO | 1 |
| Li, J; Wang, G; Wu, P; Wu, Y; Xie, C; Zhang, W | 1 |
| Brouwer, J; Comans, EF; de Bree, R; Hoekstra, OS; Leemans, CR; Pruim, J; Regelink, G; Roodenburg, JL; Vaalburg, W; van der Laan, BF; Vissink, A | 1 |
| Chung, JK; Jeong, HJ; Jeong, JM; Jung, HW; Kim, CY; Kim, DG; Kim, YK; Lee, DS; Lee, MC | 1 |
| Buchwald, C; Eigtved, A; Hansen, HS; Johansen, J; Theilgaard, SA | 1 |
| Højgaard, L; Klee, B; Kosteljanetz, M; Law, I | 1 |
| Fogarty, GB; Hicks, RJ; Peters, LJ; Rischin, D; Scott, C; Stewart, J | 1 |
| Hoefnagel, CA; Sivro-Prndelj, F; Smit, F; Valdés Olmos, RA | 1 |
| Goerres, GW; Mosna-Firlejczyk, K; Stoeckli, SJ | 1 |
| Adams, S; Baum, RP; Hertel, A; Hör, G; Mantaka, P; Niessen, A; Sengupta, S | 1 |
| Aoki, J; Endo, K; Kato, K | 1 |
| Bourguet, P | 1 |
| Fulham, MJ; Heard, RN; McCarthy, SW; McCaughan, BC; Wilkinson, MD | 1 |
| Guo, ZM; Peng, HW; Zeng, ZY | 1 |
| Bares, R; Dittmann, H; Dohmen, BM; Eichhorn, K; Eschmann, SM; Horger, M; Machulla, HJ; Paulsen, F; Wehrmann, M | 1 |
| Carreras, JL; Delgado-Bolton, RC; Fernández-Pérez, C; González-Maté, A | 1 |
| Alberini, JL; Belhocine, T; Daenen, F; Hustinx, R; Rigo, P | 1 |
| Kransdorf, MJ; O'Connor, MI; Peterson, JJ | 1 |
| Saunders, M; Wong, WL | 1 |
| Diehl, M; Döbert, N; Grünwald, F; Hamscho, N; Menzel, C; Zaplatnikov, K | 1 |
| Barry, B; Baujat, B; Gehanno, P; Lazard, DS; Le Guludec, D | 1 |
| Chung, JK; Jeong, JM; Kang, WJ; Lee, DS; Lee, MC; So, Y | 1 |
| Schöder, H; Yeung, HW | 1 |
| Aktolun, C; Berk, F; Bohuslavizki, KH; Clausen, M; Daugaard, G; Demir, H; Harmer, C; Lassen, U; Malamitsi, J; Peters, M; Plowman, PN; Raderer, M | 1 |
| Helmberger, T; Linke, R; Schroeder, M; Voltz, R | 1 |
| Biersack, HJ; Jaeger, U; Palmedo, H; Reichmann, K; Reinhardt, MJ; Rödel, R; Straehler-Pohl, HJ | 1 |
| Koshy, M; Paulino, AC; Rusthoven, KE | 1 |
| Abe, T; Fukuda, H; Ishioka, C; Iwata, R; Kanamaru, R; Kitagawa, Y; Kubota, K; Yamaguchi, K; Yamaura, G; Yoshioka, T | 1 |
| Antoch, G; Bockisch, A; Debatin, J; Egelhof, T; Fischer, M; Freudenberg, L; Goehde, S; Gutzeit, A; Hauth, E; Kühl, H | 1 |
| Comans, EF; Herder, GJ; Hoekstra, OS; Joshi, U; Teule, GJ; van der Hoeven, JJ | 1 |
| Avram, AM; Mackie, GC | 1 |
| Kraus, DH; Kutler, DI; Wong, RJ | 1 |
| Antoch, G; Bier, U; Freudenberg, L; Frings, M; Knorn, P; Maschke, M; Timmann, D | 1 |
| Hualde-Enguita, AM; Morales-Rull, JL; Ruiz-Ruiz, FJ; Saenz-Abad, D | 1 |
| Grosu, AL; Jeremic, B; Molls, M; Picchio, M; Piert, M; Schratzenstaller, U; Schwaiger, M; Weber, WA; Zimmermann, FB | 1 |
| Macapinlac, HA | 1 |
| Alavi, A; Aydin, A; Yu, JQ; Zhuang, H | 1 |
| Asakura, H; Haba, R; Mitani, M; Ohkawa, M; Seo, R; Takashima, H; Toyama, Y; Yokoe, K | 1 |
| Momose, T | 1 |
| Carpentier, P; Kirova, J; Kolesnikov-Gauthier, H; Levy, E; Meignan, M; Merlet, P; Piedbois, P; Syrota, A | 1 |
| Guille, J; Haindl, W; Pillai, D; Rossleigh, MA; Sood, R; Story, A | 1 |
| Bhargava, P; Ghesani, M; Kagetsu, NJ; Koo, CW; Rajagopalan, V; Sims-Childs, H | 1 |
| Golan, H; Linchinsky, O; Melloul, M; Volkov, O | 1 |
| Feng, YL; Liu, DJ; Pan, YJ; Wei, GY; Yu, FW; Zhang, N | 1 |
| Aschoff, P; Bihl, H; Hagen, R; Schneider, K | 1 |
| Kraus, DH; Kutler, DI; Schoder, H; Wong, RJ | 1 |
| Bisi, G; Deandreis, D; Douroukas, A; Mancini, M; Pelosi, E; Pennone, M | 1 |
| Barberet, M; Fakhry, N; Giovanni, A; Jacob, T; Mundler, O; Paris, J; Zanaret, M | 1 |
| Aschoff, P; Bihl, H; Hagen, R; Hrasky, A; Schneider, K | 1 |
| Pickles, J; Price, T | 1 |
| Dinh, M; Dinh, S; Guntinas-Lichius, O; Mueller, RP; Peter Klussmann, J; Schmidt, M; Semrau, R | 1 |
| Grahek, D; Gutman, F; Kerrou, K; Montravers, F; Périé, S; Roulet, E; Saint Guily, JL; Talbot, JN | 1 |
| Fu, Y; Ishiguro, T; Sadatou, T; Shibamoto, K; Shimokawa, N | 1 |
| Rankin, SC | 1 |
| Billotey, C; Broussolle, C; Dumontet, C; Mackey, JR; Sève, P | 1 |
| Ambrosini, V; Battista, G; Canini, R; Castellucci, P; Fanti, S; Farsad, M; Fiorentini, G; Franchi, R; Moretti, A; Nanni, C; Rampin, L; Rubello, D | 1 |
| Goerres, GW; Paul, SA; Stoeckli, SJ; von Schulthess, GK | 1 |
| Alavi, A; Basu, S | 1 |
| Katsumata, N; Sawada, M | 1 |
| Anniko, M; Blomquist, E; Ekberg, T; Engström, M; Sörensen, J; Sundin, A | 1 |
| Beppu, Y; Kawai, A; Kobayashi, E; Seki, K; Tateishi, U | 1 |
| Alberini, JL; Banal, A; Gontier, E; Le Stanc, E; Pecking, AP; Tainturier, C; Vilain, D; Wartski, M | 1 |
| Belohlavek, O; Fencl, P; Jaruskova, M; Kantorova, I; Simonova, K; Skopalova, M | 1 |
| Barge, ML; Bernard, AM; Bouriel, C; Bridji, B; Devillers, A; Garin, E; Habiba, MT; Lesimple, T; Prigent-Lejeune, F; Resche, I; Rousseau, C | 1 |
| Fujii, M; Ogawa, K; Ozawa, H; Sakamoto, K; Tagawa, T; Tomita, T; Yamaguchi, H | 1 |
| Ak, I | 1 |
| Antoch, G; Barkhausen, J; Bockisch, A; Fischer, M; Freudenberg, L; Gutzeit, A; Kuehl, H; Nassenstein, K; Stergar, H; Veit-Haibach, P | 1 |
| Jia, Q; Wei, H; Wu, ZJ; Zhang, YX | 1 |
| Bockisch, A; Eberhardt, W; Freudenberg, LS; Frilling, A; Rosenbaum-Krumme, SJ | 1 |
| Bundgaard, T; Buus, S; Grau, C; Hansen, HS; Johansen, J; Keiding, S; Kirkegaard, J; Loft, A; Overgaard, J; Overgaard, M | 1 |
| Cappellari, JO; Geisinger, KR; Greven, KM; Keyes, JW; McGuirt, WF; Raben, M; Randall, ME; Watson, NE; Williams, DW | 1 |
| Drane, WE; Mancuso, AA; Mendenhall, WM; Mukherji, SK; Parsons, JT; Stringer, S | 1 |
| Arweiler, D; Müller, S; Schipper, JH; Schrader, M; Sciuk, J | 1 |
| Greven, KM; Keyes, JW; McGuirt, WF; Watson, NE; Williams, DW | 1 |
| Hoekstra, HJ; Kole, AC; Koops, HS; Nieweg, OE; Pruim, J; Roodenburg, JL; Vaalburg, W; Vermey, A | 1 |
| AAssar, OS; Caputo, GR; Dillon, WP; Fischbein, NJ; Hawkins, RA; Kaplan, MJ; Price, DC; Singer, MI | 1 |
| Eckel, H; Jungehülsing, M; Pietrzyk, U; Scheidhauer, K; Schicha, H | 1 |
| Greven, KM; Joyce, WT; Keyes, JW; McGuirt, WF; Williams, DW | 1 |
| Nishimura, A; Ohira, S; Shinohara, M; Tomita, M | 1 |
| Bohuslavizki, KH; Clausen, M; Klutmann, S; Kröger, S; Mester, J; Sonnemann, U; Thoms, J; Werner, JA | 1 |
| Damgaard, K; Daugaard, G; Eigtved, A; Friberg, L; Lassen, U | 1 |
| Hordijk, GJ; Stokkel, MP; Terhaard, CH; van Rijk, PP | 1 |
| Matheja, P; Schober, O | 1 |
| Comans, EF; Dragoiescu, C; Hoekstra, OS; Van Riel, A | 1 |
| Bohuslavizki, KH; Buchert, R; Clausen, M; Klutmann, S; Kröger, S; Mester, J; Sonnemann, U; Werner, JA | 1 |
| Grahek, D; Kerrou, K; Monceaux, G; Montravers, F; Périé, S; St Guily, JL; Talbot, JN | 1 |
| Damm, M; Eckel, H; Jungehülsing, M; Pietrzyk, U; Scheidhauer, K; Schicha, H; Stennert, E | 1 |
| Allaoua, M; Barghouth, G; Goerres, GW | 1 |
| Carreras, JL; Domper, M; Expósito, R; Jiménez-Vicioso, A; Montz, R; Ortega, A; Pérez-Castejón, MJ | 1 |
| de Klerk, JM; Hordijk, GJ; Stokkel, MP | 1 |
| Abdel-Dayem, HM; Ajoedi, ND; Ansari, SM; Dede, F; Heiba, SI; Jana, S | 1 |
| Alberini, JL; Belhocine, T; Bolle, S; Daenen, F; Rigo, P; Rutten, I | 1 |
| Ang, KK; Byers, RM; Garden, AS; Gillenwater, AM; Morrison, WH; Nguyen, LN; Podoloff, DA; Schechter, NR | 1 |
| Courtois, A; De Dreuille, O; Foehrenbach, H; Gaillard, JF; Garcia, D; Kossowski, M; Maszelin, P; Merlet, P; Poncet, JL | 1 |
| Börner, AR; Karstens, JH; Knapp, W; Kühnel, G; Rades, D; Wildfang, I | 1 |
| Healey, J; Macapinlac, H; Núñez, R; Sánchez Salmón, A; Yeung, H | 1 |
| Börner, AR; Knapp, W; Kühnel, G; Rades, D; Schmoll, HJ; Wildfang, I | 1 |
| Hellman, P; Juhlin, C; Ladjevardi, S; Sörensen, J; Wärnberg, F | 1 |
| Choufani, G; Goldman, S; Hassid, S; Sheikholeslam-zadeh, R | 1 |
| Dagdelen, O; Hahn, K; Jäger, L; Lang, S; Pöpperl, G; Tatsch, K; Tiling, R | 1 |
| Emri, M; Erdélyi, L; Erfán, J; Esik, O; Füle, E; Lengyel, E; Lengyel, Z; Olajos, J; Trón, L | 1 |
36 review(s) available for fluorodeoxyglucose f18 and Neoplasm Metastasis, Unknown Primary
| Article | Year |
|---|---|
Impact of
Topics: Fluorodeoxyglucose F18; Humans; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
Contemporary Imaging and Reporting Strategies for Head and Neck Cancer: MRI, FDG PET/MRI, NI-RADS, and Carcinoma of Unknown Primary-
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
Fibroblast Activation Protein Inhibitor PET Imaging in Head and Neck Cancer.
Topics: Carcinoma, Squamous Cell; Female; Fibroblasts; Fluorodeoxyglucose F18; Gallium Radioisotopes; Head and Neck Neoplasms; Humans; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Squamous Cell Carcinoma of Head and Neck; Uterine Cervical Neoplasms | 2023 |
Performance of
Topics: Early Detection of Cancer; Fluorodeoxyglucose F18; Humans; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Venous Thromboembolism | 2020 |
[Cervical CUP syndrome].
Topics: Diagnostic Imaging; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Neoplasm Staging; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2020 |
18F-FDG PET/CT for detection of the primary tumor in adults with extracervical metastases from cancer of unknown primary: A systematic review and meta-analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Young Adult | 2017 |
Bone metastasis versus bone marrow metastasis? Integration of diagnosis by (18)F-fluorodeoxyglucose positron emission/computed tomography in advanced malignancy with super bone scan: two case reports and literature review.
Topics: Adult; Bone Marrow Neoplasms; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2013 |
18F-fluorodeoxyglucose positron emission tomography-computed tomography as a diagnostic tool in patients with cervical nodal metastases of unknown primary site: a meta-analysis.
Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Meta-Analysis as Topic; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
[The relevance of PET/CT for the surgical management of neuroendocrine neoplasms].
Topics: Fluorodeoxyglucose F18; Gallium Radioisotopes; Gene Expression Regulation, Neoplastic; Humans; Molecular Imaging; Multimodal Imaging; Neoplasms, Unknown Primary; Neuroendocrine Tumors; Positron-Emission Tomography; Receptors, Somatostatin; Sensitivity and Specificity; Somatostatin; Tomography, X-Ray Computed | 2014 |
Role of 2-Fluoro-2-Deoxyglucose PET/Computed Tomography in Carcinoma of Unknown Primary.
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2015 |
Combined FDG-PET/CT for the detection of unknown primary tumors: systematic review and meta-analysis.
Topics: False Positive Reactions; Fluorodeoxyglucose F18; Humans; Medical Oncology; Neoplasm Metastasis; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiology; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
PET/CT and occult primary tumors.
Topics: Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
FDG PET/CT in carcinoma of unknown primary.
Topics: Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Neoplasms, Unknown Primary; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
18F-FDG PET/CT as a diagnostic tool in patients with extracervical carcinoma of unknown primary site: a literature review.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasms, Unknown Primary; Positron-Emission Tomography; Tomography, Emission-Computed | 2011 |
FDG-PET/CT for detection of the unknown primary head and neck tumor.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Multimodal Imaging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Carcinoma of unknown primary: key radiological issues from the recent National Institute for Health and Clinical Excellence guidelines.
Topics: Biopsy; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Practice Guidelines as Topic; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
A head and neck radiologist's perspective on best practices for the usage of PET/CT scans for the diagnosis and treatment of head and neck cancers.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Lymphatic Metastasis; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Unknown Primary; Patient Care Planning; Positron-Emission Tomography; Practice Guidelines as Topic; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
A head and neck surgeon's perspective on best practices for the use of PET/CT scans for the diagnosis and treatment of head and neck cancers.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Unknown Primary; Patient Care Planning; Positron-Emission Tomography; Practice Guidelines as Topic; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
[Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in unknown primary neoplasms].
Topics: Fluorodeoxyglucose F18; Humans; Neoplasms, Unknown Primary; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
[Diagnosis of unknown primary cervical metastatic carcinoma].
Topics: Biopsy; Endoscopy; Female; Fluorodeoxyglucose F18; Humans; Neoplasms, Unknown Primary; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2003 |
Meta-analysis of the performance of 18F-FDG PET in primary tumor detection in unknown primary tumors.
Topics: False Negative Reactions; Fluorodeoxyglucose F18; Humans; Neoplasms; Neoplasms, Unknown Primary; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Diagnosis of occult bone metastases: positron emission tomography.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasms, Unknown Primary; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
[Positron-emission tomography in oncology].
Topics: Colorectal Neoplasms; Evidence-Based Medicine; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Melanoma; Neoplasms; Neoplasms, Unknown Primary; Neuroendocrine Tumors; Predictive Value of Tests; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
Positron emission imaging of head and neck cancer, including thyroid carcinoma.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Prognosis; Radiography; Radiopharmaceuticals; Subtraction Technique; Thyroid Neoplasms; Tomography, Emission-Computed | 2004 |
The role of nuclear medicine in the diagnosis of cancer of unknown origin.
Topics: Biomarkers, Tumor; Bone and Bones; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasms, Unknown Primary; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2004 |
The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neck; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2004 |
Functional imaging in head and neck cancer.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Prognosis | 2005 |
Positron emission tomography for radiation treatment planning.
Topics: Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Neoplasms; Neoplasms, Unknown Primary; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Prostatic Neoplasms; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2005 |
[Clinical application of positron emission tomography and 18FDG to brain tumor].
Topics: Aged; Astrocytoma; Brain Diseases; Brain Neoplasms; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Humans; Lymphoma; Methionine; Necrosis; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiation Injuries; Radiopharmaceuticals; Radiotherapy | 2005 |
The current status of positron-emission tomography scanning in the evaluation and follow-up of patients with head and neck cancer.
Topics: Carcinoma, Squamous Cell; Combined Modality Therapy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Unknown Primary; Radionuclide Imaging; Radiopharmaceuticals; Tomography, X-Ray Computed | 2006 |
Synchronous bilateral tonsillar carcinoma: role of fluoro-deoxyglucose positron emission tomography scanning in detecting occult primary tumours in metastatic nodal disease of the head and neck.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neck; Neck Dissection; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Tonsillar Neoplasms; Tonsillectomy | 2006 |
[FDG-PET in localization of cancers of unknown primary origin].
Topics: Fluorodeoxyglucose F18; Humans; Neoplasms, Unknown Primary; Paraneoplastic Syndromes, Nervous System; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
The role of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography in disseminated carcinoma of unknown primary site.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Neoplasms, Unknown Primary; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2007 |
Cancer of unknown primary.
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
Can positron emission tomography improve the quality of care for head-and-neck cancer patients?
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Neoplasm, Residual; Neoplasms, Unknown Primary; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Unknown primary detected by FDG-PET. A review of the present indications of FDG-PET in head and neck cancers.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
12 trial(s) available for fluorodeoxyglucose f18 and Neoplasm Metastasis, Unknown Primary
| Article | Year |
|---|---|
Additional testing following screening strategies for occult malignancy diagnosis in patients with unprovoked venous thromboembolism.
Topics: Aged; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Positron-Emission Tomography; Tomography, X-Ray Computed; Venous Thromboembolism | 2017 |
In patients with unprovoked VTE, does the addition of FDG PET/CT to a limited occult cancer screening strategy offer good value for money? A cost-effectiveness analysis from the publicly funded health care systems.
Topics: Adult; Aged; Aged, 80 and over; Cost-Benefit Analysis; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; France; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Ontario; Patient Acceptance of Health Care; Positron Emission Tomography Computed Tomography; Quality-Adjusted Life Years; Venous Thromboembolism | 2018 |
Limited screening with versus without (18)F-fluorodeoxyglucose PET/CT for occult malignancy in unprovoked venous thromboembolism: an open-label randomised controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Intention to Treat Analysis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Venous Thromboembolism; Whole Body Imaging | 2016 |
Volume-based predictive biomarkers of sequential FDG-PET/CT for sunitinib in cancer of unknown primary: identification of the best benefited patients.
Topics: Adult; Antineoplastic Agents; Biomarkers; China; Female; Fluorodeoxyglucose F18; Humans; Indoles; Male; Middle Aged; Neoplasms, Unknown Primary; Outcome Assessment, Health Care; Patient Selection; Positron Emission Tomography Computed Tomography; Prevalence; Prognosis; Pyrroles; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Sunitinib; Survival Rate; Treatment Outcome; Tumor Burden | 2017 |
[Impact of positron emission tomography on clinical management of potentially resectable non-small-cell lung cancer: a French prospective multicenter study].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Colonic Neoplasms; Decision Making; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Mediastinoscopy; Middle Aged; Neoplasm Staging; Neoplasms, Unknown Primary; Palliative Care; Patient Care Planning; Pneumonectomy; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Whole Body Imaging | 2010 |
Lymph node metastasis of squamous cell carcinoma from an unknown primary: impact of positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cohort Studies; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck; Neoplasms, Unknown Primary; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
[18F]FLT PET for diagnosis and staging of thoracic tumours.
Topics: Adult; Aged; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms, Unknown Primary; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thoracic Neoplasms; Tomography, Emission-Computed | 2003 |
Whole-body positron emission tomography using fluorodeoxyglucose in patients with metastases of unknown primary tumours (CUP syndrome).
Topics: Adult; Aged; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Radiography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Syndrome; Tomography, Emission-Computed; Whole-Body Counting | 2003 |
[Is coincidence detection emission tomography (CDET) as reliable as positron emission tomography (PET) in head and neck cancer?].
Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Neoplasms, Unknown Primary; Radiography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Differentiation of mediastinal FDG uptake observed in patients with non-thoracic tumours.
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Mediastinum; Middle Aged; Neoplasms, Unknown Primary; Radionuclide Imaging; Reproducibility of Results; Sensitivity and Specificity; Thoracic Neoplasms | 2004 |
Cervical lymph node metastases of unknown origin: primary tumor detection with whole-body positron emission tomography/computed tomography.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Use of a coincidence gamma camera to detect primary tumor with 18fluoro-2-deoxy-glucose in cervical lymph node metastases from an unknown origin.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Evaluation Studies as Topic; Fluorodeoxyglucose F18; Gamma Cameras; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck; Neoplasms, Unknown Primary; Prospective Studies; Radionuclide Imaging | 2000 |
171 other study(ies) available for fluorodeoxyglucose f18 and Neoplasm Metastasis, Unknown Primary
| Article | Year |
|---|---|
The usefulness of [18F]FDG-PET/CT in detecting and managing cancers with unknown primary site depends on histological subtype.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Neuroendocrine; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Young Adult | 2021 |
Incidental uptake of fluorodeoxyglucose in the Waldeyer's ring and risk of oropharyngeal malignancy.
Topics: Fluorodeoxyglucose F18; Humans; Incidental Findings; Neoplasms, Unknown Primary; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2022 |
IgA Nephropathy in a Patient With Metastatic Carcinoma of Unknown Primary: Findings on 18F-FDG PET/MRI.
Topics: Adult; Carcinoma; Fluorodeoxyglucose F18; Glomerulonephritis, IGA; Humans; Magnetic Resonance Imaging; Male; Neoplasms, Unknown Primary; Radiopharmaceuticals; Sensitivity and Specificity | 2022 |
Sensitivity of [18F]FDG PET/CT and classification of the primary tumor site in patients with carcinoma of unknown primary.
Topics: Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2022 |
Case Report: Focal leptomeningeal disease, atypical cancer of unknown primary site.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Meningeal Neoplasms; Neoplasms, Unknown Primary; Peru; Positron Emission Tomography Computed Tomography | 2022 |
Topics: Electrons; Fluorodeoxyglucose F18; Humans; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Venous Thromboembolism | 2022 |
Prediction of extranodal extension in oropharyngeal cancer patients and carcinoma of unknown primary: value of metabolic tumor imaging with hybrid PET compared with MRI and CT.
Topics: Extranodal Extension; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Neoplasms, Unknown Primary; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2023 |
The additional role of [68Ga]Ga-FAPI-04 PET/CT in patients with unknown primary lesion with a negative or equivocal [18F]FDG.
Topics: Aged; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Prospective Studies; Quinolines | 2023 |
Evaluation of radiation treatment volumes for unknown primaries of the head and neck in the era of FDG PET.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiation Dosage; Survival Analysis; Treatment Outcome | 2020 |
Comparative cohort study of volumetric modulated arc therapy for squamous cell cancer of unknown primary in the head and neck-Involved neck only versus mucosal irradiation.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Mucositis; Neoplasms, Unknown Primary; Organs at Risk; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Retrospective Studies; Survival Rate; Xerostomia | 2020 |
Sentinel node theory helps tracking of primary lesions of cancers of unknown primary.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Sentinel Lymph Node; Sentinel Lymph Node Biopsy; Young Adult | 2020 |
CORR Insights®: Does PET/CT Aid in Detecting Primary Carcinoma in Patients with Skeletal Metastases of Unknown Primary?
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2020 |
The impact of 18F-FDG PET/CT in the clinical management of patients with lymph node metastasis of unknown primary origin.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2021 |
Feasibility of prognosis assessment for cancer of unknown primary origin using texture analysis of 18F-fluorodeoxyglucose PET/computed tomography images of largest metastatic lymph node.
Topics: Adult; Aged; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies | 2021 |
Value of 18F-FDG PET/CT in patients with hepatic metastatic carcinoma of unknown primary.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Case-Control Studies; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2020 |
Diagnostic performance of 18F-FDG PET/CT for the detection of occult primary tumors in squamous cell carcinoma of unknown primary in the head and neck: a single-center retrospective study.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sensitivity and Specificity | 2021 |
Role of FDG PET/CT for detection of primary tumor in patients with extracervical metastases from carcinoma of unknown primary.
Topics: Aged; Carcinoma; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2021 |
Unknown primary head and neck squamous cell carcinoma in the era of fluorodeoxyglucose-positron emission tomography/CT and intensity-modulated radiotherapy.
Topics: Aged; Analysis of Variance; Carcinoma, Squamous Cell; Cohort Studies; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Netherlands; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Radiotherapy, Intensity-Modulated; Retrospective Studies; Risk Assessment; Survival Analysis; Treatment Outcome | 2017 |
Metastatic Neuroendocrine Carcinoma of Unknown Origin Arising in the Femoral Nerve Sheath.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Etoposide; Female; Femoral Nerve; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Nerve Sheath Neoplasms; Palliative Care; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
Bone marrow necrosis secondary to metastatic adenocarcinoma revealed by 18F-FDG PET/CT: A clinical case report.
Topics: Adenocarcinoma; Adult; Bone Marrow Neoplasms; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Necrosis; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
Diagnostic value of
Topics: Adult; Aged; Aged, 80 and over; Austria; Brain Neoplasms; Female; Fluorodeoxyglucose F18; France; Humans; Male; Middle Aged; Neoplasm Grading; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Switzerland | 2018 |
Detection of unknown primary tumor in patients presented with brain metastasis by F-18 fluorodeoxyglucose positron emission tomography/computed tomography.
Topics: Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2018 |
Palatine tonsil SUVmax on FDG PET-CT as a discriminator between benign and malignant tonsils in patients with and without head and neck squamous cell carcinoma of unknown primary.
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Palatine Tonsil; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck | 2019 |
18F-FDG PET-CT in Unknown-Source of Elevated Serum Carcinoembryonic Antigen (CEA) Level.
Topics: Adult; Aged; Carcinoembryonic Antigen; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2018 |
The Impact of a Stepwise Approach to Primary Tumor Detection in Squamous Cell Carcinoma of the Neck With Unknown Primary.
Topics: Aged; Biopsy; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Laryngoscopy; Male; Middle Aged; Neoplasm Staging; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Robotic Surgical Procedures; Survival Rate; Tonsillectomy | 2019 |
FDG PET/CT for metastatic squamous cell carcinoma of unknown primary of the head and neck.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2019 |
A Stepwise Approach to Identify the Clinical Role of 18F-FDG PET/CT in Patients With Suspicious Bone Metastasis From an Unknown Primary Site.
Topics: Aged, 80 and over; Bone Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography | 2019 |
Nivolumab-Associated Pulmonary and Bone Sarcoidosis in a Patient With Melanoma of Unknown Primary.
Topics: Bone Diseases; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lymphadenopathy; Male; Melanoma; Middle Aged; Neoplasms, Unknown Primary; Nivolumab; Positron Emission Tomography Computed Tomography; Sarcoidosis | 2019 |
FDG PET/CT detects clinically occult pancreatic cancer in a case of Von Hippel-Lindau syndrome.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasms, Unknown Primary; Pancreatic Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed; von Hippel-Lindau Disease | 2013 |
Screening for occult malignancy with FDG-PET/CT in patients with unprovoked venous thromboembolism.
Topics: Aged; Anticoagulants; Biomarkers, Tumor; Blood Coagulation Factors; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Neoplasms, Unknown Primary; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Venous Thromboembolism | 2013 |
The added value of 18F-fluorodeoxyglucose positron emission tomography computed tomography in patients with neck lymph node metastases from an unknown primary malignancy.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2013 |
The role of 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in the management of patients with carcinoma of unknown primary.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Scotland; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Prognostic relevance of (18)F-FDG PET/CT in carcinoma of unknown primary.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
Detection of occult primary tumors in patients with cervical metastases of unknown primary tumors: comparison of (18)F FDG PET/CT with contrast-enhanced CT or CT/MR imaging-prospective study.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2015 |
The role of tonsillectomy in the initial diagnostic work-up of head and neck squamous cell carcinoma of unknown primary.
Topics: Aged; Aged, 80 and over; Biopsy; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Diseases; Male; Middle Aged; Neoplasm Invasiveness; Neoplasms, Unknown Primary; Palatine Tonsil; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Tonsillectomy | 2014 |
Utility of F-18 fluorodeoxyglucose posıtron emıssıon tomography/computed ın carcınoma of unknown primary.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radioisotopes; Tomography, X-Ray Computed; Young Adult | 2014 |
11C-Choline and 18F-FDG PET/CT in the Detection of Occult Prostate Cancer in the Context of a Paraneoplastic Syndrome.
Topics: Aged; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neoplasms, Unknown Primary; Paraneoplastic Syndromes; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
[Role of 18FDG-PET/CT in the management and gross tumor volume definition for radiotherapy of head and neck cancer; single institution experiences based on long-term follow-up].
Topics: Adult; Aged; Aged, 80 and over; Cancer Care Facilities; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Hungary; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2015 |
Histogram Analysis of Apparent Diffusion Coefficients for Occult Tonsil Cancer in Patients with Cervical Nodal Metastasis from an Unknown Primary Site at Presentation.
Topics: Adult; Aged; Biopsy; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Tonsillar Neoplasms; Tonsillectomy | 2016 |
Diaphragm and Laryngeal FDG Uptake With Hiccups.
Topics: Adenocarcinoma; Diaphragm; Fluorodeoxyglucose F18; Hiccup; Humans; Larynx; Male; Middle Aged; Multimodal Imaging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Role of 18-Fludeoxyglucose positron emission tomography-computed tomography and subsequent panendoscopy in head and neck squamous cell carcinoma of unknown primary.
Topics: Carcinoma, Squamous Cell; Endoscopy; False Positive Reactions; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tongue Neoplasms | 2016 |
18 FDG-PET/CT: 21st century approach to leukemic tumors in 124 cases.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Infant; Leukemia; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasms, Unknown Primary; Positron-Emission Tomography; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2016 |
Abnormal FDG and MIBG Activity in the Bones in a Patient With Neuroblastoma Without Detectable Primary Tumor.
Topics: 3-Iodobenzylguanidine; Bone Neoplasms; Child, Preschool; Fluorodeoxyglucose F18; Humans; Male; Neoplasms, Unknown Primary; Neuroblastoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
Neuroendocrine Malignancy Diagnosed via CT-Guided Percutaneous Biopsy of an Isolated Abnormal Cardiophrenic Lymph Node: Case Report.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Image-Guided Biopsy; Lymph Nodes; Male; Middle Aged; Neoplasms, Unknown Primary; Neuroendocrine Tumors; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
A follow-up analysis of positron emission tomography/computed tomography in detecting hidden malignancies at the time of diagnosis of membranous nephropathy.
Topics: Adult; Aged; Cohort Studies; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Glomerulonephritis, Membranous; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Proteinuria; Retrospective Studies | 2016 |
Occult Mediastinal Yolk Sac Tumor Producing α-Fetoprotein Detected by 18F-FDG PET/CT.
Topics: Adult; alpha-Fetoproteins; Biological Transport; Endodermal Sinus Tumor; Fluorodeoxyglucose F18; Humans; Male; Mediastinal Neoplasms; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography | 2016 |
Impact on Patient Management of [18F]-Fluorodeoxyglucose-Positron Emission Tomography (PET) Used for Cancer Diagnosis: Analysis of Data From the National Oncologic PET Registry.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms; Neoplasms, Unknown Primary; Paraneoplastic Syndromes; Positron-Emission Tomography; Registries; Tomography, X-Ray Computed | 2016 |
The role of 18F-FDG PET-CT in the detection of unknown primary malignancy: a retrospective study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2016 |
Defining risk groups of patients with cancer of unknown primary site and cervical nodal metastases by F-18 fluorodeoxyglucose positron emission tomography and computed tomography imaging.
Topics: Cervical Vertebrae; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multivariate Analysis; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Risk Assessment; Risk Factors; Survival Analysis | 2016 |
Cervical lymph node metastases of squamous cell carcinoma of unknown origin: the diagnostic value of FDG PET/CT and clinical outcome.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2017 |
Bilateral Huge Incidentalomas of Isolated Adrenal Metastases From Unknown Primary Melanoma Revealed by 18F-FDG PET/CT.
Topics: Adrenal Gland Neoplasms; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Melanoma; Middle Aged; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
Hybrid imaging for detection of carcinoma of unknown primary: A preliminary comparison trial of whole-body PET/MRI versus PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Whole Body Imaging | 2016 |
Impact of 3T multiparametric MRI and FDG-PET-CT in the evaluation of occult primary cancer with cervical node metastasis.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neck; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2016 |
PET/MR Outperforms PET/CT in Suspected Occult Tumors.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2017 |
Tuberculosis mimicking metastases by malignancy in FDG PET/CT.
Topics: Biopsy; Bone Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Ribs; Tuberculosis, Osteoarticular | 2017 |
18-FDG PET in the diagnosis of laterocervical metastases from occult carcinoma.
Topics: Aged; Aged, 80 and over; Biopsy, Fine-Needle; Cohort Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Enhancement; Immunohistochemistry; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck; Neck Dissection; Neoplasm Staging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Prospective Studies; Risk Assessment; Sensitivity and Specificity | 2009 |
Evaluation of the role of 18FDG-PET/CT in radiotherapy target definition in patients with head and neck cancer.
Topics: Adult; Aged; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Tomography, X-Ray Computed; Tumor Burden | 2008 |
Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors.
Topics: Adult; Aged; Cohort Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2009 |
Occult myofibroblastic sarcoma detected on FDG-PET performed for cancer screening.
Topics: Female; Fluorodeoxyglucose F18; Humans; Mass Screening; Middle Aged; Muscle Neoplasms; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma | 2008 |
[(18)F-FDG PET-CT in detecting the primary tumor in patients with metastatic cancers of unknown primary origin].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms, Unknown Primary; Ovarian Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2008 |
Nodal metastasis from occult thyroid cancer detected by FDG PET-CT in a patient with 2 known malignancies.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Neoplasms, Unknown Primary; Positron-Emission Tomography; Prostatic Neoplasms; Thyroid Neoplasms; Tomography, X-Ray Computed | 2009 |
[Clinical diagnosis of primary unknown cancer-the present situation and problems].
Topics: Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Humans; Neoplasms, Unknown Primary; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
Application of 18F-fluorodeoxyglucose positron emission tomography in diagnosis of malignant diseases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2009 |
Fluorodeoxyglucose-positron-emission tomography imaging of head and neck squamous cell cancer.
Topics: Biopsy, Fine-Needle; Carcinoma, Squamous Cell; Disease Progression; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Neoplasms, Multiple Primary; Neoplasms, Unknown Primary; Otorhinolaryngologic Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed; Tumor Burden; Ultrasonography | 2010 |
The value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in carcinoma of an unknown primary: diagnosis and follow-up.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Neoplasms, Unknown Primary; Positron-Emission Tomography; Sensitivity and Specificity; Survival Analysis; Tomography, X-Ray Computed; Young Adult | 2010 |
Role of 2-deoxy-2-[F-18] fluoro-D-glucose positron emission tomography in the management of bone and soft-tissue metastases.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Soft Tissue Neoplasms; Young Adult | 2010 |
[Positron emission tomography/computed tomography in patients with cancer of unknown primary origin].
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
Imaging of HIV-associated Kaposi sarcoma; F-18-FDG-PET/CT and In-111-bevacizumabscintigraphy.
Topics: Fluorodeoxyglucose F18; HIV Infections; Humans; Indium Radioisotopes; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radioisotopes; Sarcoma, Kaposi; Tomography, X-Ray Computed | 2010 |
Two occult primaries discovered on PET/CT in a patient with paraparesis.
Topics: Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Paraparesis; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
Role of 18F-FDG PET in detecting primary site in the patient with primary unknown carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Carcinoma, Squamous Cell; Diagnostic Imaging; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Statistics, Nonparametric; Survival Rate | 2010 |
The real additional value of FDG-PET in detecting the occult primary tumour in patients with cervical lymph node metastases of unknown primary tumour.
Topics: Biopsy; Carcinoma, Squamous Cell; Diagnostic Imaging; Endoscopy; False Negative Reactions; False Positive Reactions; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2010 |
Occult squamous cell carcinoma of the uvula detected by F-18 FDG PET/CT in a case of carcinoma of unknown primary in the head and neck.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Mouth Neoplasms; Neoplasms, Unknown Primary; Positron-Emission Tomography; Tomography, X-Ray Computed; Uvula | 2010 |
Interesting image. The search for primary tumor in a patient with oncogenic osteomalacia: F-18 FDG PET resolves the conundrum.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Neoplasms, Connective Tissue; Neoplasms, Unknown Primary; Osteomalacia; Paraneoplastic Syndromes; Positron-Emission Tomography | 2010 |
Subacute trismus in a kidney transplant recipient.
Topics: Aged; Carcinoma; Diagnosis, Differential; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Immunocompromised Host; Kidney Transplantation; Male; Masseter Muscle; Muscle Neoplasms; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Trismus | 2010 |
Clinical implication of (18)F-FDG PET/CT in carcinoma of unknown primary.
Topics: Adult; Aged; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2011 |
FDG-PET/CT-guided biopsy of bone metastases sets a new course in patient management after extensive imaging and multiple futile biopsies.
Topics: Adenocarcinoma; Aged; Biopsy; Carcinoma, Small Cell; Carcinoma, Transitional Cell; Fluorodeoxyglucose F18; Humans; Male; Neoplasms, Unknown Primary; Neuroendocrine Tumors; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Spinal Neoplasms; Spine; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2011 |
PET and PET/CT for unknown primary tumors.
Topics: Adult; Aged; Fluorodeoxyglucose F18; Humans; Male; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals | 2011 |
Neuroendocrine carcinoma of the larynx presenting as a primary unknown carcinoma.
Topics: Aged, 80 and over; Carcinoma, Neuroendocrine; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Male; Neoplasms, Unknown Primary; Positron-Emission Tomography | 2012 |
Clinical impact of FDG PET-CT in patients with potentially operable metastatic colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Neoplasms, Unknown Primary; Peritoneal Neoplasms; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Unnecessary Procedures | 2011 |
Navigation-assisted localisation and resection of subclinical metastatic malignant melanoma of unknown primary based on 18-fluorodeoxyglcose positron emission tomography computed tomography fusion imaging.
Topics: Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Lymph Node Excision; Lymphatic Metastasis; Melanoma; Middle Aged; Multimodal Imaging; Neck Dissection; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Scalp; Skin Neoplasms; Surgery, Computer-Assisted; Tomography, X-Ray Computed; Whole Body Imaging | 2012 |
Characterization of adrenal metastatic cancer using FDG PET/CT.
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Aged; Carcinoma; China; Cohort Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Hyperplasia; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Risk; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Usefulness of F-18 FDG PET/CT as one-stop-shop imaging modality for diagnosis of occult primary and estimation of disease burden in patients with intraocular masses.
Topics: Adult; Eye Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Tomography, X-Ray Computed; Tumor Burden | 2012 |
Predictive value of positron emission tomography-computed tomography image fusion in the diagnosis of head and neck cancer: does it really improve staging and management?
Topics: Biopsy; Carcinoma; Clinical Competence; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Incidental Findings; Lymphatic Metastasis; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Unknown Primary; Observer Variation; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Value of fused positron emission tomography CT in detecting primaries in patients with primary unknown cervical lymph node metastasis.
Topics: Adult; Aged; Biomarkers, Tumor; Biopsy; Endoscopy; Female; Fluorodeoxyglucose F18; Humans; Lymphoscintigraphy; Male; Middle Aged; Multimodal Imaging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiography, Abdominal; Radiography, Thoracic; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Occult colon cancer with initial cutaneous metastatic manifestation: PET/CT detection.
Topics: Aged; Colonic Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Skin Neoplasms; Tomography, X-Ray Computed | 2012 |
Clinical value of 18F-FDG PET-CT in detecting primary tumor for patients with carcinoma of unknown primary.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma; Carcinoma, Squamous Cell; Digestive System Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Hemangiosarcoma; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Neoplasms, Unknown Primary; Ovarian Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prostatic Neoplasms; Retrospective Studies; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed; Urologic Neoplasms | 2012 |
[Large vessel vasculitis diagnosed by positron emission tomography/computed tomography presenting with non-specific symptoms].
Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Middle Aged; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Takayasu Arteritis | 2012 |
[The role of PET-CT in detecting unknown primary tumour in patients with cervical lymph node metastases].
Topics: Adult; Aged; Carcinoma; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Lymphoma; Male; Melanoma; Middle Aged; Multimodal Imaging; Neck; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
A prospective comparison of 18F-FDG PET/CT and CT as diagnostic tools to identify the primary tumor site in patients with extracervical carcinoma of unknown primary site.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2012 |
18F-FDG PET detection of unknown primary malignancy in dermatomyositis.
Topics: Dermatomyositis; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasms, Unknown Primary; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography as an effective diagnostic workup in cervical metastasis of carcinoma from an unknown primary tumor.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Male; Middle Aged; Multimodal Imaging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
[(18)F-fluorodeoxyglucose positron emission tomography/computed tomography and unknown origin primary tumor. Current usefulness and future perspectives].
Topics: Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
Utility of quantitative 18 F-fluorodeoxyglucose uptake measurement to identify occult tonsillar carcinoma in patients with cervical metastasis of unknown primary tumours: a retrospective case-control study.
Topics: Carcinoma, Squamous Cell; Case-Control Studies; Chi-Square Distribution; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neck; Neoplasm Staging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Statistics, Nonparametric; Tomography, X-Ray Computed; Tonsillar Neoplasms | 2013 |
[Usefulness of (18)F-fluorodeoxyglucose-positron emission tomography-computerized tomography in the identification of the primary tumor in patients with cancer of unknown origin].
Topics: Adult; Aged; Aged, 80 and over; Biopsy; False Positive Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2013 |
Prediction of survival and evaluation of diagnostic accuracy whole body 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in the detection carcinoma of unknown primary origin.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
Clinical value of whole-body F-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with carcinoma of unknown primary.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; China; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasms, Unknown Primary; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Whole Body Imaging; Young Adult | 2013 |
FDG positron emission tomography to manage patients with an occult primary carcinoma and metastasis outside the cervical lymph nodes.
Topics: Blue Cross Blue Shield Insurance Plans; Carcinoma; Device Approval; Fluorodeoxyglucose F18; Humans; Insurance Coverage; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Neoplasms, Unknown Primary; Outcome Assessment, Health Care; Radiopharmaceuticals; Sensitivity and Specificity; Technology Assessment, Biomedical; Tomography, Emission-Computed; United States; United States Food and Drug Administration | 2002 |
Detection of unknown primary tumours and distant metastases in patients with cervical metastases: value of FDG-PET versus conventional modalities.
Topics: Adenocarcinoma; Carcinoma; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasms, Unknown Primary; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Usefulness of whole-body (18)F-FDG PET in patients with suspected metastatic brain tumors.
Topics: Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Implication of 18F-fluoro-2-deoxy-D-glucose positron emission tomography on management of carcinoma of unknown primary in the head and neck: a Danish cohort study.
Topics: Actuarial Analysis; Bayes Theorem; Carcinoma, Squamous Cell; Cohort Studies; Denmark; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Neoplasms, Unknown Primary; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
Detection of unknown primary tumours in patients with cerebral metastases using whole-body 18F-flouorodeoxyglucose positron emission tomography.
Topics: Adult; Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Radiopharmaceuticals; Tomography, Emission-Computed; Whole-Body Irradiation | 2002 |
The usefulness of fluorine 18-labelled deoxyglucose positron emission tomography in the investigation of patients with cervical lymphadenopathy from an unknown primary tumor.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Male; Middle Aged; Neoplasms, Unknown Primary; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Hypertrophic osteoarthropathy on bone scintigraphy related to a mediastinal tumour of unknown origin imaged by FDG-PET.
Topics: Bone and Bones; Fluorodeoxyglucose F18; Humans; Mediastinal Neoplasms; Neoplasms, Unknown Primary; Osteoarthropathy, Primary Hypertrophic; Radiopharmaceuticals; Tomography, Emission-Computed; Whole-Body Counting | 2003 |
PET with 2-[F-18]-fluoro-2-deoxy-D-glucose (FDG) in patients with cancer of unknown primary (CUP): influence on patients' diagnostic and therapeutic management.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Utility of FDG-PET in differential diagnosis of benign and malignant fractures in acute to subacute phase.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Fractures, Bone; Fractures, Spontaneous; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed | 2003 |
FDG-PET in paraneoplastic neuropathy.
Topics: Ataxia; Carcinoma, Small Cell; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Paraneoplastic Syndromes; Radionuclide Imaging; Radiopharmaceuticals; Sensation Disorders | 2003 |
The impact of FDG PET on the management of occult primary head and neck tumours.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasms, Unknown Primary; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Antibody-positive paraneoplastic neurologic syndromes: value of CT and PET for tumor diagnosis.
Topics: Adenocarcinoma; Adult; Aged; Antibody Specificity; Autoantibodies; Autoimmune Diseases of the Nervous System; Carcinoma; Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Neuroblastoma; Neurons; Ovarian Neoplasms; Paraneoplastic Polyneuropathy; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Spiral Computed | 2004 |
[PET/CT imaging in head and neck tumors].
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Otorhinolaryngologic Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2004 |
FDG PET and gallium scintigraphy for diagnosis of an advanced jejunal adenocarcinoma with distant metastases.
Topics: Adenocarcinoma; Citrates; Fluorodeoxyglucose F18; Gallium; Humans; Image Enhancement; Jejunal Neoplasms; Lymphatic Metastasis; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Severity of Illness Index | 2004 |
Unknown primary tumors: detection with dual-modality PET/CT--initial experience.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
In search of an unknown primary tumour presenting with extracervical metastases: the diagnostic performance of FDG-PET.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2004 |
FDG PET imaging features of epidermolysis bullosa complicated by squamous cell carcinoma.
Topics: Adult; Diagnosis, Differential; Epidermolysis Bullosa; Female; Fluorodeoxyglucose F18; Humans; Leg; Neoplasms, Squamous Cell; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
Strategies in detection of the primary tumour in anti-Yo associated paraneoplastic cerebellar degeneration.
Topics: Adenocarcinoma; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Magnetic Resonance Imaging; Middle Aged; Neoplasms, Unknown Primary; Paraneoplastic Cerebellar Degeneration; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Whole-Body Counting | 2005 |
Positron emission tomography: useful in detecting metastatic cancer of unknown primary site.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
FDG-PET in head and neck, and thyroid cancer.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Thyroid Neoplasms | 2005 |
Detection of bone marrow metastases by FDG-PET and missed by bone scintigraphy in widespread melanoma.
Topics: Adult; Bone Marrow Neoplasms; Bone Neoplasms; Diagnosis, Differential; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Neoplasm Invasiveness; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
Unknown primary carcinoma, diagnosed as inflammatory breast cancer,and successfully treated with trastuzumab and vinorelbine.
Topics: Adenocarcinoma; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Diseases; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Neoplasms, Unknown Primary; Radiopharmaceuticals; Receptor, ErbB-2; Tomography, Emission-Computed; Trastuzumab; Treatment Outcome; Vinblastine; Vinorelbine | 2005 |
FDG PET in patients with cancer of an unknown primary.
Topics: Adenocarcinoma; Adult; Aged; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Neoplasms, Unknown Primary; Positron-Emission Tomography; Prospective Studies; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Whole-Body Counting | 2005 |
Superiority of F-18 FDG PET imaging for detection of a pheochromocytoma.
Topics: Adult; Female; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Image Enhancement; Kidney Neoplasms; Neoplasms, Unknown Primary; Pheochromocytoma; Positron-Emission Tomography; Pregnancy; Radiopharmaceuticals | 2006 |
Incidental detection of clinically occult pituitary adenoma on whole-body FDG PET imaging.
Topics: Adenoma; Aged; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Neoplasms, Unknown Primary; Pituitary Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Whole Body Imaging | 2006 |
FDG-PET imaging in Merkel cell carcinoma - value of head-to-toe scan.
Topics: Carcinoma, Merkel Cell; Fluorodeoxyglucose F18; Humans; Leg; Male; Middle Aged; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Soft Tissue Neoplasms; Whole Body Imaging | 2005 |
[Diagnostic value of dual-head 18F-FDG imaging in metastatic lesion with unknown primary tumour].
Topics: Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Neoplasms, Unknown Primary; Positron-Emission Tomography | 2005 |
[The integrated PET/CT: technological advance in diagnostics of head and neck recurrencies and CUP?].
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Palpation; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed | 2006 |
Role of whole body positron emission tomography/computed tomography scan with 18F-fluorodeoxyglucose in patients with biopsy proven tumor metastases from unknown primary site.
Topics: Adult; Aged; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Italy; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Whole Body Imaging | 2006 |
[Contribution of 18-F-FDG PET for detection of head and neck carcinomas with an unknown primary tumor].
Topics: Adult; Aged; Carcinoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2006 |
[Significance of PET and integrated PET/CT in the diagnostics of occult primary tumors].
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Nasopharynx; Neoplasms, Unknown Primary; Otorhinolaryngologic Neoplasms; Palatine Tonsil; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed; Tonsillectomy | 2006 |
Diagnostic work-up and outcome of cervical metastases from an unknown primary.
Topics: Adult; Aged; Aged, 80 and over; Biopsy, Needle; Combined Modality Therapy; Disease-Free Survival; Endoscopy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neck Dissection; Neoplasms, Unknown Primary; Otorhinolaryngologic Neoplasms; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
[Detection of unknown primary tumor in a patient with cerebellar metastasis using FDG PET-CT: case report].
Topics: Aged; Cerebellar Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasms, Unknown Primary; Positron-Emission Tomography; Tomography, X-Ray Computed | 2006 |
PET in face and neck tumours.
Topics: Facial Neoplasms; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Second Primary; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
18F-FDG PET/CT in the assessment of carcinoma of unknown primary origin.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
FDG PET and PET/CT for the detection of the primary tumour in patients with cervical non-squamous cell carcinoma metastasis of an unknown primary.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2007 |
FDG-PET in the clinical management of carcinoma of unknown primary with metastatic cervical lymphadenopathy: shifting gears from detecting the primary to planning therapeutic strategies.
Topics: Carcinoma; Clinical Trials as Topic; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neck; Neoplasms, Unknown Primary; Positron-Emission Tomography; Practice Patterns, Physicians'; Radiopharmaceuticals | 2007 |
A case of primary unknown carcinoma with lymphatic spread.
Topics: Cystadenocarcinoma, Serous; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasms, Unknown Primary; Radiography; Radiopharmaceuticals; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2006 |
Clinical impact of positron emission tomography (PET) with (18F)fluorodeoxyglucose (FDG) in head and neck tumours.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2007 |
Bilateral adrenal gland metastasis from malignant fibrous histiocytoma: value of [F-18]FDG PET-CT for diagnosis of occult metastases.
Topics: Adrenal Gland Neoplasms; Aged; Female; Fluorodeoxyglucose F18; Histiocytoma, Malignant Fibrous; Humans; Liver Neoplasms; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2006 |
In search of an unknown primary tumour presenting with cervical metastases: performance of hybrid FDG-PET-CT.
Topics: Adult; Aged; Aged, 80 and over; Cervical Vertebrae; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Enhancement; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2007 |
Prognostic and diagnostic accuracy of [18F]FDG-PET/CT in 190 patients with carcinoma of unknown primary.
Topics: Adult; Aged; Czech Republic; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Subtraction Technique; Survival Analysis; Survival Rate; Tomography, X-Ray Computed | 2007 |
Impact of PET-FDG in the diagnosis and therapeutic care of patients presenting with metastases of unknown primary.
Topics: DNA-Binding Proteins; Fluorodeoxyglucose F18; Humans; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiography, Thoracic; Tomography, X-Ray Computed; Transcription Factors | 2007 |
[Clinical study of 28 cases of cervical lymph node metastasis from an unknown primary carcinoma].
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasms, Unknown Primary; Positron-Emission Tomography; Prognosis; Survival Rate | 2007 |
F-18 FDG imaging of an asymptomatic sacrococcygeal pilonidal sinus in a patient with malignant disease.
Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasms, Unknown Primary; Pelvic Neoplasms; Pilonidal Sinus; Radionuclide Imaging; Radiopharmaceuticals; Sacrococcygeal Region; Sacrum | 2007 |
[The role of whole body 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in the management of unknown primary tumors].
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Prospective study of 18FDG-PET in the detection and management of patients with lymph node metastases to the neck from an unknown primary tumor. Results from the DAHANCA-13 study.
Topics: Adult; Aged; Carcinoma; Endoscopy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasms; Neoplasms, Unknown Primary; Positron-Emission Tomography; Practice Guidelines as Topic; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Adjuvant; Sensitivity and Specificity | 2008 |
Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation.
Topics: Carcinoma; Carcinoma, Squamous Cell; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymph Node Excision; Lymph Nodes; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Oropharyngeal Neoplasms; Paranasal Sinus Neoplasms; Prognosis; Prospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1994 |
Occult primary tumors of the head and neck: detection with 2-[F-18] fluoro-2-deoxy-D-glucose SPECT.
Topics: Biopsy; Carcinoma, Squamous Cell; Contrast Media; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasms, Unknown Primary; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 1996 |
[Positron emission tomography for primary tumor detection in lymph node metastases with unknown primary tumor].
Topics: Biopsy; Deoxyglucose; Diagnosis, Differential; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasms, Unknown Primary; Otorhinolaryngologic Neoplasms; Prospective Studies; Tomography, Emission-Computed | 1996 |
FDG PET in head and neck cancer.
Topics: Adult; Aged; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Second Primary; Neoplasms, Unknown Primary; Radiopharmaceuticals; Salivary Gland Neoplasms; Tomography, Emission-Computed | 1997 |
Detection of unknown occult primary tumors using positron emission tomography.
Topics: Adult; Aged; Bone Neoplasms; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Radiopharmaceuticals; Skin Neoplasms; Tomography, Emission-Computed | 1998 |
Metastatic head and neck cancer: role and usefulness of FDG PET in locating occult primary tumors.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
Detection of unknown primary cancer with fluor-deoxy-glucose positron emission tomography.
Topics: Biopsy, Needle; Carcinoma; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Neoplasms; Nasopharynx; Neoplasms, Unknown Primary; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
Occult primary tumors of the head and neck: lack of benefit from positron emission tomography imaging with 2-[F-18]fluoro-2-deoxy-D-glucose.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Neoplasms, Unknown Primary; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
[Evaluation of 18F-FDG positron emission tomography (PET) in the detection of unknown primary tumors].
Topics: Aged; Animals; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms, Unknown Primary; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
[F-18 FDG PET for detection of occult primary tumor in patients with lymphatic metastases of the neck region].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Otorhinolaryngologic Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
18F-FDG whole body positron emission tomography (PET) in patients with unknown primary tumours (UPT).
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Prospective Studies; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed; Tongue Neoplasms; Uterine Cervical Neoplasms | 1999 |
The detection of unknown primary tumors in patients with cervical metastases by dual-head positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Radiopharmaceuticals; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 1999 |
[18F-FDG whole-body positron-emission tomography (PET) in patients with unknown primary tumors].
Topics: Fluorodeoxyglucose F18; Humans; Neoplasms, Unknown Primary; Radiopharmaceuticals; Tomography, Emission-Computed; Whole-Body Counting | 2000 |
F-18 fluorodeoxyglucose positron emission tomographic imaging: in search of an unknown primary tumor.
Topics: Adult; Female; Fluorodeoxyglucose F18; Hand; Humans; Neoplasms, Unknown Primary; Radiopharmaceuticals; Reflex Sympathetic Dystrophy; Sarcoma; Tomography, Emission-Computed | 2000 |
FDG PET detection of unknown primary tumors.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed | 2000 |
2[F]-fluoro-2-deoxy-D-glucose positron emission tomography is a sensitive tool for the detection of occult primary cancer (carcinoma of unknown primary syndrome) with head and neck lymph node manifestation.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
[Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) in ORL and pulmonary oncology].
Topics: Fluorodeoxyglucose F18; Glucose; Humans; Lung Neoplasms; Lymph Nodes; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Unknown Primary; Otorhinolaryngologic Neoplasms; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
Localization of a tumor of unknown origin by means of 18-fluorodeoxyglucose positron emission tomography.
Topics: Aged; Aged, 80 and over; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Neoplasms, Unknown Primary; Radiopharmaceuticals; Rectal Neoplasms; Tomography, Emission-Computed | 2000 |
Fluorodeoxyglucose positron emission tomography, a new technique for increasing the detection rate of coincident thyroid cancer in head and neck oncology.
Topics: Adult; Aged; Blood Glucose; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Multiple Primary; Neoplasms, Unknown Primary; Otorhinolaryngologic Neoplasms; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed | 2000 |
Metastatic thyroid cancer occurring as an unknown primary lesion: the role of F-18 FDG positron emission tomography.
Topics: Aged; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms, Unknown Primary; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed; Whole-Body Counting | 2001 |
A case of cerebral metastases of unknown origin: utility of F-18 FDG positron emission tomography to localize the primary tumor.
Topics: Aged; Brain Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasms, Unknown Primary; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
[Positron emission tomography in head and neck oncology: five cases].
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Pharyngeal Neoplasms; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
[The value of positron emission tomography (PET) in the treatment of patients with cancer of unknown primary (CUP)].
Topics: Adult; Aged; Aged, 80 and over; Bone and Bones; Endoscopy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Mammography; Middle Aged; Neoplasms, Unknown Primary; Radiopharmaceuticals; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
[FGD PET in a patient with pseudofractures from osteomalacia].
Topics: Adult; Antineoplastic Agents; Bone Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Fractures, Spontaneous; Humans; Hyperparathyroidism; Lymphoma; Male; Neoplasms, Unknown Primary; Osteomalacia; Radiopharmaceuticals; Tissue Distribution; Tomography, Emission-Computed | 2002 |
Localised disease in cancer of unknown primary (CUP): the value of positron emission tomography (PET) for individual therapeutic management.
Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Endoscopy; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasms, Unknown Primary; Predictive Value of Tests; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
[A case report. FDG-PET in occult breast cancer].
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Neoplasms, Unknown Primary; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
[Correlation of FDG-PET and MRI/CT with histopathology in primary diagnosis, lymph node staging and diagnosis of recurrency of head and neck cancer].
Topics: Adult; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Unknown Primary; Otorhinolaryngologic Neoplasms; Prognosis; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
[PET scan in patients with epipharyngeal tumors].
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Hyperplasia; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Neoplasms, Unknown Primary; Pharyngeal Neoplasms; Radiopharmaceuticals; Recurrence; Retrospective Studies; Tomography, Emission-Computed; Treatment Outcome | 2002 |